SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH H impact

IONS: FDA Approves TRYNGOLZA

IONS' TRYNGOLZA approved by FDA to reduce triglycerides and risk of acute pancreatitis in patients with severe hypertriglyceridemia

IONS

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.